Human papillomavirus vaccine efficacy and effectiveness against cancer

S Kamolratanakul, P Pitisuttithum - Vaccines, 2021 - mdpi.com
Human papillomavirus (HPV) is the most common sexually transmitted infection, with 15
HPV types related to cervical, anal, oropharyngeal, penile, vulvar, and vaginal cancers …

[HTML][HTML] Human papillomavirus vaccine against cervical cancer: Opportunity and challenge

R Wang, W Pan, L Jin, W Huang, Y Li, D Wu, C Gao… - Cancer letters, 2020 - Elsevier
Cervical cancer is one of the most common cancers threatening women's health, and the
persistent infection of high-risk human papillomavirus (HPV) is closely related to the …

Primary care guidance for persons with human immunodeficiency virus: 2020 update by the HIV Medicine Association of the Infectious Diseases Society of America

MA Thompson, MA Horberg, AL Agwu… - Clinical infectious …, 2021 - academic.oup.com
Advances in antiretroviral therapy (ART) have made it possible for persons with human
immunodeficiency virus (HIV) to live a near expected life span, without progressing to AIDS …

Human papillomavirus vaccines: an updated review

L Cheng, Y Wang, J Du - Vaccines, 2020 - mdpi.com
Human papillomavirus (HPV) vaccines, which were introduced in many countries in the past
decade, have shown promising results in decreasing HPV infection and related diseases …

Prophylactic and therapeutic HPV vaccines: current scenario and perspectives

Y Mo, J Ma, H Zhang, J Shen, J Chen… - Frontiers in cellular …, 2022 - frontiersin.org
Persistent human papillomavirus (HPV) infection is recognized as the main cause of cervical
cancer and other malignant cancers. Although early detection and treatment can be …

Lifetime prevalence of cervical cancer screening in 55 low-and middle-income countries

JM Lemp, JW De Neve, H Bussmann, S Chen… - Jama, 2020 - jamanetwork.com
Importance The World Health Organization is developing a global strategy to eliminate
cervical cancer, with goals for screening prevalence among women aged 30 through 49 …

Human papillomavirus vaccines

LE Markowitz, JT Schiller - The Journal of infectious diseases, 2021 - academic.oup.com
Human papillomavirus (HPV) vaccines are among the most effective vaccines available, the
first to prevent infection by a mucosatropic sexually transmitted infectious agent and to do so …

Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors

C Simoens, PPL Martin‐Hirsch - Cochrane database of …, 2018 - cochranelibrary.com
Background Persistent infection with high‐risk human papillomaviruses (hrHPV) types is
causally linked with the development of cervical precancer and cancer. HPV types 16 and …

Human papillomavirus vaccination and cervical cancer risk

L Rahangdale, C Mungo, S O'Connor, CJ Chibwesha… - Bmj, 2022 - bmj.com
Persistent human papillomavirus infection is the central cause of cervical cancer, the leading
cause of cancer death among women worldwide. Clear evidence from both randomized …

Cervical cancer

PA Cohen, A Jhingran, A Oaknin, L Denny - The Lancet, 2019 - thelancet.com
Each year, more than half a million women are diagnosed with cervical cancer and the
disease results in over 300 000 deaths worldwide. High-risk subtypes of the human …